We have recently reported severe airway obstruction and bronchial hype
rresponsiveness (BHR) in fatal asthma compared with patients without a
history of near-fatal asthma. Based on these findings, we evaluated w
hether aspirin-induced asthma (AIA) is a risk factor for asthma mortal
ity by analyzing pulmonary function and BHR. FEV1.0% and methacholine
inhalation threshold were significantly lower in the fatal asthma grou
p compared with the AIA and non-AIA groups. However, there were no sig
nificant differences between the AIA and non-AIA groups. Our results s
uggested that AIA is not a risk factor for asthma mortality if avoidan
ce of aspirin and aspirin-like drugs is assured.